ACMR three-lens brief
Evidence-based stock research on ACMR. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Analyst mean target $117.75 — 63% above current (8 analysts). · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Analyst mean target $117.75 — 63% above current (8 analysts).
- Negative free cash flow last quarterly (-$186.61M).
ACMR closed at $72.39 (-1.95%) as of 2026-09-11. Market cap: $5.04B. P/E (trailing) 34.8. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $117.75 — 63% above current (8 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; negative free cash flow last quarterly (-$186.61M).. Last quarter: Revenue $292.92M, net income $88.98M, free cash flow -$186.61M.
Why three lenses on ACMR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ACMRacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ACMR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ACMR brief"></iframe>